Literature DB >> 33639186

Racism and Kidney Health: Turning Equity Into a Reality.

Dinushika Mohottige1, Clarissa J Diamantidis2, Keith C Norris3, L Ebony Boulware4.   

Abstract

Kidney disease continues to manifest stark racial inequities in the United States, revealing the entrenchment of racism and bias within multiple facets of society, including in our institutions, practices, norms, and beliefs. In this perspective, we synthesize theory and evidence to describe why an understanding of race and racism is integral to kidney care, providing examples of how kidney health disparities manifest interpersonal and structural racism. We then describe racialized medicine and "colorblind" approaches as well as their pitfalls, offering in their place suggestions to embed antiracism and an "equity lens" into our practice. We propose examples of how we can enhance kidney health equity by enhancing our structural competency, using equity-focused race consciousness, and centering investigation and solutions around the needs of the most marginalized. To achieve equitable outcomes for all, our medical institutions must embed antiracism and equity into all aspects of advocacy, policy, patient/community engagement, educational efforts, and clinical care processes. Organizations engaged in kidney care should commit to promoting structural equity and eliminating potential sources of bias across referral practices, guidelines, research agendas, and clinical care. Kidney care providers should reaffirm our commitment to structurally competent patient care and educational endeavors in which empathy and continuous self-education about social drivers of health and inequity, racism, and bias are integral. We envision a future in which kidney health equity is a reality for all. Through bold collective and sustained investment, we can achieve this critical goal.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Health equity; discrimination; health disparities; kidney disease; nephrology; race; race-based medicine; socioeconomic status (SES); structural racism

Year:  2021        PMID: 33639186     DOI: 10.1053/j.ajkd.2021.01.010

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

1.  Use of Race in Kidney Research and Medicine: Concepts, Principles, and Practice.

Authors:  Dinushika Mohottige; L Ebony Boulware; Chandra L Ford; Camara Jones; Keith C Norris
Journal:  Clin J Am Soc Nephrol       Date:  2021-11-17       Impact factor: 8.237

2.  Acknowledging Socioecological Systems to Address the Systemic Racial Disparities in Children with Kidney Disease.

Authors:  Anne E Dawson; Julia E LaMotte; O N Ray Bignall
Journal:  J Am Soc Nephrol       Date:  2022-06-29       Impact factor: 14.978

3.  Kidney Health Disparities: The Goal is Elimination.

Authors:  Donald E Wesson
Journal:  J Am Soc Nephrol       Date:  2022-06-21       Impact factor: 14.978

4.  Navigating to Kidney Health Equity.

Authors:  Derek M Griffith; Ebele M Umeukeje
Journal:  J Am Soc Nephrol       Date:  2022-06-21       Impact factor: 14.978

5.  Trainee Perspectives on Race, Antiracism, and the Path toward Justice in Kidney Care.

Authors:  Anna S Heffron; Rohan Khazanchi; Naomi Nkinsi; Joel A Bervell; Jessica P Cerdeña; James A Diao; Leo Gordon Eisenstein; Nali Julia Gillespie; Natasha Hongsermeier-Graves; Maddy Kane; Karampreet Kaur; Luis E Seija; Jennifer Tsai; Darshali A Vyas; Angela Y Zhang
Journal:  Clin J Am Soc Nephrol       Date:  2022-06-07       Impact factor: 10.614

6.  Race, Social Class, and CKD: The Way Forward.

Authors:  Marino A Bruce; Keith C Norris
Journal:  Kidney Med       Date:  2021-12-17

Review 7.  Health inequities and the inappropriate use of race in nephrology.

Authors:  Nwamaka D Eneanya; L Ebony Boulware; Jennifer Tsai; Marino A Bruce; Chandra L Ford; Christina Harris; Leo S Morales; Michael J Ryan; Peter P Reese; Roland J Thorpe; Michelle Morse; Valencia Walker; Fatiu A Arogundade; Antonio A Lopes; Keith C Norris
Journal:  Nat Rev Nephrol       Date:  2021-11-08       Impact factor: 42.439

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.